Clinical Trial Update: In Vitro Immunomodulation in Membranous Nephropathy Relapses [NA]

View source ↗

Summary

A clinical trial investigating in vitro immunomodulation in membranous nephropathy relapses has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extramembranous Glomerulopathy
• Membranous Nephropathy

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Extramembranous Glomerulopathy | NA | Status: COMPLETED